Literature DB >> 12618699

The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair.

M J Bown1, M L Nicholson, P R F Bell, R D Sayers.   

Abstract

BACKGROUND: Organ failure is a major cause of morbidity and mortality after abdominal aortic aneurysm (AAA) repair. The aim of this study was to determine the relationships between the systemic inflammatory response syndrome (SIRS), organ failure, and mortality after AAA repair and to determine whether the clinical monitoring of SIRS was a useful adjunct to clinical method.
METHODS: One hundred consecutive patients undergoing open AAA repair were prospectively studied. Patients were divided into three groups: those undergoing elective AAA repair, those with symptomatic but nonruptured AAA, and those with ruptured AAA. The presence of SIRS and organ failure was recorded on a daily basis for each patient until discharge or death.
RESULTS: Most patients had SIRS develop during the postoperative period: 89% of the elective group, 92% of the emergency nonruptured (urgent) group, and 100% of the ruptured group. Multiorgan failure occurred in 3.8% of the elective group, 38% of the urgent group, and 64% of the ruptured AAA group. After ruptured AAA repair, the concurrent absence of both SIRS and any organ failure for 48 hours had a sensitivity of 93% and a specificity of 91% as a predictive indicator of subsequent survival to hospital discharge. Patients in whom multiorgan failure developed after ruptured AAA repair had a significantly higher mortality rate (69%) than those who did not (0%; P =.001; 95% CI for the difference, 30.2% to 85.8%).
CONCLUSION: The differences in the incidence rate of multiorgan failure between the patient groups compared with the high incidence rate of SIRS in all patient groups supports the two-hit hypothesis of multiorgan failure. The presence of multiorgan failure after ruptured AAA repair is associated with poor outcome. The absence of SIRS and organ failure in these patients is a good predictive indicator of survival.

Entities:  

Mesh:

Year:  2003        PMID: 12618699     DOI: 10.1067/mva.2003.39

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  17 in total

1.  Systemic Inflammatory Response Syndrome is an Independent Predictor of One-Year Mortality in Patients with Acute Myocardial Infarction.

Authors:  Wei-Chieh Huang; Ruey-Hsing Chou; Chun-Chin Chang; Chien-Yi Hsu; Yu-Chen Ku; Hsiu-Fen Huang; Yi-Chieh Chen; Po-Hsun Huang
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

2.  The Systemic Inflammatory Response Syndrome (SIRS)--number and type of positive criteria predict interventions and outcomes in acute surgical admissions.

Authors:  James A Stephenson; Gianpiero Gravante; Nicholas A Butler; Roberto Sorge; Rob D Sayers; Matt J Bown
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

3.  Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair.

Authors:  Takashi Kohno; Toshihisa Anzai; Hideyuki Shimizu; Hidehiro Kaneko; Yasuo Sugano; Shingo Yamada; Tsutomu Yoshikawa; Akitoshi Ishizaka; Ryohei Yozu; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

4.  APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.

Authors:  Danielle G Souza; Dirk Esser; Roberta Bradford; Angélica T Vieira; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

5.  Translocation of bacterial NOD2 agonist and its link with inflammation.

Authors:  Oh Yoen Kim; Antoine Monsel; Michèle Bertrand; Jean-Marc Cavaillon; Pierre Coriat; Minou Adib-Conquy
Journal:  Crit Care       Date:  2009-07-28       Impact factor: 9.097

6.  Prospective randomized controlled trial to evaluate "fast-track" elective open infrarenal aneurysm repair.

Authors:  Bernd M Muehling; Gisela Halter; Gunter Lang; Hubert Schelzig; Peter Steffen; Florian Wagner; Rainer Meierhenrich; Ludger Sunder-Plassmann; Karl-Heinz Orend
Journal:  Langenbecks Arch Surg       Date:  2008-02-14       Impact factor: 3.445

7.  A prospective randomized trial comparing traditional and fast-track patient care in elective open infrarenal aneurysm repair.

Authors:  Bernd Muehling; Hubert Schelzig; Peter Steffen; Rainer Meierhenrich; Ludger Sunder-Plassmann; Karl-Heinz Orend
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

8.  Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis.

Authors:  Allison Sutherland; Mervyn Thomas; Roslyn A Brandon; Richard B Brandon; Jeffrey Lipman; Benjamin Tang; Anthony McLean; Ranald Pascoe; Gareth Price; Thu Nguyen; Glenn Stone; Deon Venter
Journal:  Crit Care       Date:  2011-06-20       Impact factor: 9.097

9.  HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms.

Authors:  Jan Willem W Haveman; Aad P van den Berg; Eric L G Verhoeven; Maarten W N Nijsten; Jan J A M van den Dungen; Hauw T The; Jan H Zwaveling
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  Systemic inflammation and repair of abdominal aortic aneurysm.

Authors:  Andrew L Tambyraja; Raymond Dawson; Domenico Valenti; John A Murie; Roderick T Chalmers
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.